XML 39 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Cash Flow Statements (Unaudited) - USD ($)
 9 Months Ended
Oct. 04, 2015
Sep. 28, 2014
Cash flows from operating activities:    
Net (loss) income $ (21,723,000) $ 863,000
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization 7,022,000 7,987,000
Deferred income taxes 2,436,000 0
Stock-based compensation expense 717,000 1,235,000
Deferred revenue recognized (4,200,000) (6,493,000)
Deferred loan costs recognized 1,929,000 58,000
Gain on sale of assets (7,423,000) (4,000)
Provision for excess and obsolete inventory 1,305,000 897,000
Other noncash items (1,478,000) (135,000)
Contributions to pension plans (315,000) (907,000)
Changes in operating assets and liabilities:    
Accounts receivable 23,384,000 (23,041,000)
Inventory 2,154,000 (1,955,000)
Other current assets (4,332,000) (835,000)
Accounts payable (12,051,000) 22,993,000
Accrued and other liabilities 860,000 5,376,000
Net cash (used in) provided by operating activities (11,715,000) 6,039,000
Cash flows from investing activities:    
Capital expenditures, net (1,155,000) (4,462,000)
Proceeds from sale of assets 15,700,000 8,000
Net cash provided by (used in) investing activities 14,545,000 (4,454,000)
Cash flows from financing activities:    
Net change in debt under revolving credit agreements (10,738,000) 1,000,000
Proceeds from note payable – related party 5,500,000 0
Debt modification costs (2,335,000) 0
Common stock repurchases 0 (357,000)
Indirect repurchase of shares for minimum statutory tax withholdings (77,000) (420,000)
Cash dividends paid (410,000) (1,225,000)
Proceeds from issuance of common stock 0 4,000
Net cash used in financing activities (8,060,000) (998,000)
Net (decrease) increase in cash and cash equivalents (5,230,000) 587,000
Cash and cash equivalents at beginning of period 7,003,000 18,674,000
Cash and cash equivalents at end of period $ 1,773,000 $ 19,261,000